Help Fund an Early-Career Researcher
Eighty-eight cents of every dollar you give does directly to cancer research. Cancer Research Saves Lives.
Related Articles
Explore MRD Dynamics With Isa-VRd in Newly Diagnosed Multiple Myeloma: Insights From Philippe Moreau, MD
Dr Moreau highlights key findings on MRD negativity dynamics from IMROZ and their future implications for patients with newly diagnosed multiple myeloma.
2024 Most Read Articles | Blood Advances | American Society of Hematology
2024 Most Read Articles | Blood Advances | American Society of Hematology Top Ten Most Read Articles in 2024 Blood Advances is pleased to announce…
2024 Most Read Articles | Blood Advances | American Society of Hematology
2024 Most Read Articles | Blood Advances | American Society of Hematology Top Ten Most Read Articles in 2024 Blood Advances is pleased to announce…
SHR-A1811 Shows Initial Antitumor Activity, Tolerability in HER2+ Breast Cancer
SHR-A1811 monotherapy demonstrated high clinical activity and was well tolerated in patients with HER2-positive breast cancer.
State Cancer Profiles
State Cancer Profiles is an interactive map engine produced in collaboration between the National Cancer Institute and Centers for Disease Control and Prevention. It was…
Optimal Strategies for Managing Adverse Events with CAR-T Therapy in Multiple Myeloma
Experts on multiple myeloma present patient cases and have a comprehensive discussion on the management of adverse events associated with CAR T-cell therapy, including CRS,…
Translational Science Training Course
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell…
Feasibility of app-based interactive care plans in breast cancer survivors
Daniela Stan, MD, Mayo Clinic, Rochester, MN, provides an overview of a study assessing an app-based interactive care plan (ICP) for breast cancer survivors post-treatment.…
Shaking Up Gynecologic Cancer Treatment With Mentorship and Patient-Centric Care
Carol Aghajanian, MD, has stayed at the forefront of innovation in gynecologic oncology—and she credits her patients and their conversations in retaining that role.
Frailty in Older Adults with Prostate Cancer
Older adults with all stages of prostate cancer are prone to developing frailty. These patients should have a frailty assessment and be managed by a…
